Logo image of HUSN

HUDSON CAPITAL INC (HUSN) Stock Fundamental Analysis

NASDAQ:HUSN - VGG4645C1178 - Common Stock

1.66
+0.08 (+5.06%)
Last: 5/26/2022, 8:01:15 PM
Fundamental Rating

2

Overall HUSN gets a fundamental rating of 2 out of 10. We evaluated HUSN against 100 industry peers in the Financial Services industry. HUSN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HUSN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year HUSN has reported negative net income.
HUSN Yearly Net Income VS EBIT VS OCF VS FCFHUSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -77.26%
ROE 81.06%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HUSN Yearly ROA, ROE, ROICHUSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -500 -1K -1.5K -2K

1.3 Margins

Industry RankSector Rank
OM -36569600%
PM (TTM) -88271400%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HUSN Yearly Profit, Operating, Gross MarginsHUSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -1K -2K -3K -4K

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HUSN has been reduced compared to 1 year ago.
There is no outstanding debt for HUSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HUSN Yearly Shares OutstandingHUSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M
HUSN Yearly Total Debt VS Total AssetsHUSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

HUSN has an Altman-Z score of -68.79. This is a bad value and indicates that HUSN is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for HUSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -68.79
ROIC/WACCN/A
WACCN/A
HUSN Yearly LT Debt VS Equity VS FCFHUSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 22.92 indicates that HUSN has no problem at all paying its short term obligations.
A Quick Ratio of 22.92 indicates that HUSN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 22.92
Quick Ratio 22.92
HUSN Yearly Current Assets VS Current LiabilitesHUSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.96% over the past year.
Measured over the past years, HUSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.95% on average per year.
The Revenue for HUSN has decreased by -99.99% in the past year. This is quite bad
EPS 1Y (TTM)77.96%
EPS 3YN/A
EPS 5Y-24.95%
EPS Q2Q%80.28%
Revenue 1Y (TTM)-99.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HUSN Yearly Revenue VS EstimatesHUSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 5M 10M 15M 20M 25M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUSN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HUSN Price Earnings VS Forward Price EarningsHUSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.16
HUSN Per share dataHUSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HUSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HUDSON CAPITAL INC

NASDAQ:HUSN (5/26/2022, 8:01:15 PM)

1.66

+0.08 (+5.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-16 2022-05-16
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner Change-89.14%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.63M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1201840
P/FCF N/A
P/OCF N/A
P/B 4.01
P/tB N/A
EV/EBITDA -4.16
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.41
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -77.26%
ROE 81.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -36569600%
PM (TTM) -88271400%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 22.92
Quick Ratio 22.92
Altman-Z -68.79
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.96%
EPS 3YN/A
EPS 5Y-24.95%
EPS Q2Q%80.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A